ArticleCureus2026
Gastric Amyloidosis Presenting as Refractory Dyspepsia: A Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric amyloidosis is a rare condition characterized by localized amyloid deposition in the stomach, often mimicking more common gastrointestinal disorders and presenting diagnostic challenges due to nonspecific symptoms and endoscopic findings. A 62-year-old man with six months of dyspepsia unresponsive to proton pump inhibitors underwent endoscopy, which revealed nodular mucosal changes and erosions in the gastric antrum. Biopsy confirmed amyloid deposits with Congo red staining, and systemic involvement was excluded through comprehensive evaluation. The patient improved with symptomatic management. This case underscores the importance of considering isolated gastric amyloidosis in patients with refractory dyspepsia and atypical gastric lesions, with early biopsy and Congo red staining being essential for accurate diagnosis and appropriate care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.